Phase Ib Study of SC Milatuzumab in SLE

Clinical trial NCT01845740 · COMPLETED

Trial details

NCT number: NCT01845740
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lupus Erythematosus, Cutaneous Lupus Erythematosus, Discoid Lupus Erythematosus, Systemic Lupus Vasculitis, Central Nervous System Lupus Nephritis

Start date: 2007-01-01
Primary completion: 2009-06-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.